CSA

April 22, 2021

Pharmacy Agrees to Pay to Resolve Alleged Violations

Booneville Pharmacy Agrees to Pay $250,000 to Resolve Alleged Violations of the Controlled Substances Act LEXINGTON, KY (STL.News) A Booneville, Kentucky pharmacy, Public Drug Company, d/b/a Booneville Discount Drugs, has agreed to pay the United States $250,000 to settle civil allegations that it failed to make and maintain complete and...

Read More
March 9, 2021

Dr. Hugo Rojas Agrees to Pay $350,000 to Resolve Allegations

San Antonio Physician, Dr. Hugo A. Rojas Agrees to Pay $350,000 to Resolve Allegations that He Pre-Signed Prescriptions and Issued Prescriptions without Appropriate Examinations (STL.News) Dr. Hugo A. Rojas, owner of Hugo A. Rojas, M.D., P.A., and Family Clinics of San Antonio, has agreed to pay $350,000.00 under a civil...

Read More
March 3, 2021

Pharmacy Settles Controlled Substances Act Allegations

Meriden Pharmacy Settles Controlled Substances Act Allegations (STL.News)Leonard C Boyle, Acting United States Attorney for the District of Connecticut, today announced that GRAEBER’S PHARMACY, INC., of Meriden, and its owner, ROGER DeZINNO (collectively, “Graeber’s Pharmacy”), entered into a civil settlement agreement with the federal government to resolve allegations that it...

Read More
February 8, 2021

DOJ’s Commitment to Preventing Opioid Abuse

Over $1.1M in Civil Settlements Reaffirm DOJ’s Commitment to Preventing Opioid Abuse (STL.News) The United States Attorney’s Office has collected $792,000 in civil penalties as two more civil Controlled Substances Act (CSA) investigations have settled, announced U.S. Attorney Gregg N. Sofer and Drug Enforcement Administration (DEA) Special Agent in Charge...

Read More
February 3, 2021

Vistapharm, Inc. Agrees To Pay $325,000

Pharmaceutical Distributor Vistapharm, Inc. Agrees To Pay $325,000 To Resolve Alleged Violations Of The Controlled Substances Act Tampa, FL (STL.News) United States Attorney Maria Chapa Lopez announces that Vistapharm, Inc. has agreed to pay the United States $325,000 to resolve allegations that Vistapharm violated the Controlled Substances Act (CSA) by...

Read More